Učitavanje...
Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...
Spremljeno u:
| Izdano u: | J Transl Med |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714097/ https://ncbi.nlm.nih.gov/pubmed/31462312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2035-8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|